Items Tagged ‘Liquid biopsy’
May 7, 2019
Targeting bile duct cancer – meet Mitesh Borad, M.D.
By Sharon Rosen 
The search for treatment targets for patients with bile duct cancer, also known as cholangiocarcinoma, has taken a 360 degree turn, offering new hope for patients. That’s according to Mitesh Borad, M.D., deputy director for Center for Individualized Medicine Biomarker Discovery Program at Mayo Clinic’s Arizona campus, Dr. Borad and his colleagues are using new […]
Tags: #Dr. Mitesh Borad, #liver cancer, #targeted therapies, bile duct cancer, Biomarker Discovery Program, cholangiocarcinoma, fibroblast growth factor receptor (FGFR) inhibitors, Genetic Testing, genomics, Liquid biopsy, mayo clinic, Mayo Clinic Center for Individualized Medicine
May 15, 2018
Arresting melanoma’s molecular drivers
Article by Barbara Toman Melanoma, the skin cancer often associated with sun exposure, is on the rise and has no reliable cure. May is National Melanoma and Skin Cancer Awareness Month, aimed at increasing early detection and treatment of this aggressive disease. Mayo Clinic is at the forefront of these efforts. The Center for Individualized Medicine […]
Tags: #Dr. Minetta Liu, #skin cancer, cancer genomics, DNA Testing, Dr. Aleksandar Sekulic, Liquid biopsy, Mayo Clinic Arizona, Mayo Clinic Center for Individualized Medicine, Mayo Clinic Rochester, Melanoma
July 21, 2016
Liquid Biopsies Offer Hope for Earlier Treatment, Better Tracking of Ovarian Cancer
By Sharon Rosen
Ovarian cancer has long been one of the trickiest forms of cancer to diagnose and treat. It often goes unnoticed until the late stages. For most women, the cancer goes into remission after the first round of treatment but then returns with a vengeance. Three-quarters of the time, ovarian cancer comes back with a tumor […]
Tags: center for individualized medicine, diagnostic, Dr. George Vasmatzis, early detection for ovarian cancer, Liquid biopsy, mate-pair sequencing, mayo clinic, medical research, ovarian cancer, whole genome sequencing
November 9, 2015
Case for ‘Liquid Biopsy’ to Track Patient’s Cancer Building One Study at a Time
By Jeff Briggs
Circulating tumor DNA in blood could inform physicians on best treatments for individual patients A new study published last week of patients with breast cancer adds to the growing evidence that detecting cancer DNA circulating in the blood can guide patient treatment. A team of researchers, including scientists from the Translational Genomics Research Institute (TGen), has […]
Tags: breast cancer, center for individualized medicine, DNA, Dr. Keith Stewart, Dr. Muhammed Martaza, individualized medicine, Liquid biopsy, Precision Medicine